CEA Projects in Liver diseases

Non-commercially Funded Projects

•National Research Fund (2022-)

•Korea Disease Control and Prevention (2021-2022)

•Ajou University (2021-)

•The Korean Association for the Study of the Liver (2020-2021)

•Severance Hospital (2019-2020)

Publications

Lee H, Yoo JJ, Ahn SH, Kim BK. New evidence of oral branched-chain amino acid supplementation on the prognosis of patients with advanced liver disease. Clinical and Translational Gastroenterology. (Accepted on October 13, 2022)

Lee H, Kim BK. Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database. J Gastroenterol Hepatol. 2022 Jul 21. doi: 10.1111/jgh.15962. Epub ahead of print. PMID: 35862281  

Lee H, Jang S, Kim BK. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level<2,000 IU/mL. Hepatology International. 2022;16(2):294-305. 

Lee HW, Lee H (co-first author), Kim BK, Jang Y, Chang JY, Kim DY. Cost-Effectiveness of Screening and Treatment of Chronic Hepatitis C. Clinical and Molecular Hepatology. 2022;28(2):164-173. 

Lee H, Kim BK, Lee L, Jang SI, Ahn SH. Cost-effectiveness analysis of antiviral therapy for untreated minimally active chronic hepatitis B to prevent liver disease progression.  Clinical and Translational Gastroenterology, 2021;12(2) doi: 10.14309/ctg.0000000000000299